CONE-BEAM COMPUTER TOMOGRAPHY (CBCT) POSITION VERIFICATION FOR UPPER-OESOPHAGEAL CANCER: EVALUATION OF TREATMENT DURING RADIOTHERAPY AT K HOSPITAL
Main Article Content
Abstract
Background and aims: The purpose of this study was to evaluate upper oesophageal cancer treatment effect based on anatomical variations using deformable image registration methods of ConeBeam CT (CBCT). Patients and methods: In 40 patients with upper esophageal cancer, four “clipbox” (C) volumes were defined: C-planning target volume (PTV), C-carina, C-vertebrae, C-thorax. The set-up corrections (translational and rotational) for C-PTV were compared to the ones using C-carina, C-vertebrae and C-thorax. Results: From 40 patients, 1120 ConeBeam CT-scans were registered. The highest concordance in set-up corrections between C-PTV and C-carina in the superior/inferior direction was found at 60,7%; in the right/left and anterior/posterior directions was at 88,7% and 82% respectively. C-vertebrae in ConeBeam CT was found with the highest setup errors. Conclusion: Anatomical changes can result in the correction of patient positioning errors which are difficult to be detected during clinical examination. To achieve the best radiotherapy treatment result for upper-oesophageal tumours, it is vital to calculate accurate planning target volume.
Article Details
Keywords
Oesophageal cancer, Cone-Beam CT, set-up margins, anatomical variations
References
2. Lesueur P, Servagi-Vernat S. Détermination des marges du volume cible anatomoclinique au volume cible prévisionnel pour la radiothérapie conformationnelle des cancers de l’œsophage. Cancer/Radiothérapie. 2016;20(6-7):651-656. doi:10.1016/j.canrad.2016.07.065
3. Cho Y, Moseley DJ, Siewerdsen JH, Jaffray DA. Accurate technique for complete geometric calibration of cone-beam computed tomography systems: Accurate technique for geometric calibration of cone-beam CT systems. Med Phys. 2005;32(4):968-983. doi:10.1118/1.1869652
4. Nguyễn Đức Lợi (2015), Đánh giá hiệu quả phác đồ hóa xạ trị đồng thời và một số yếu tố tiên lượng ung thư biểu mô thực quản giai đoạn III-IV tại Bệnh viện K., Luận án tiến sỹ y học, Đại học Y Hà Nội.
5. Lordick F, Mariette C, Haustermans K, Obermannová R, Arnold D. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2016;27:v50-v57. doi:10.1093/ annonc/mdw329
6. Napier KJ, Scheerer M, Misra S. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol. 2014;6(5):112-120. doi:10.4251/wjgo.v6.i5.112
7. Kato K, Muro K, Minashi K, et al. Phase II Study of Chemoradiotherapy With 5-Fluorouracil and Cisplatin for Stage II–III Esophageal Squamous Cell Carcinoma: JCOG Trial (JCOG 9906). International Journal of Radiation Oncology*Biology*Physics. 2011;81(3):684-690. doi:10.1016/j.ijrobp.2010.06.033
8. Ohtsu A, Boku N, Muro K, et al. Definitive Chemoradiotherapy for T4 and/or M1 Lymph Node Squamous Cell Carcinoma of the Esophagus. JCO. 1999;17(9):2915-2915. doi:10.1200/ JCO.1999.17.9.2915
9. Li QQ, Liu MZ, Hu YH, Liu H, He ZY, Lin HX. Definitive concomitant chemoradiotherapy with docetaxel and cisplatin in squamous esopheageal carcinoma. Diseases of the Esophagus. 2010; 23 (3): 253-259. doi:10.1111/j.1442-2050. 2009. 01003.x